Top Growth Stocks Revenue
Hims & Hers Health: Partnership With Novo Nordisk Causes Sensation
Guardant Health: The Silent Revolution in Cancer Diagnostics
Blood-based cancer diagnostics on the way to becoming the new standard – with billion-dollar potential....
Duolingo's Next Move
The learning platform is entering a new growth area in the digital education market with chess –...
StoneX: The Winner That's not in the Headlines
StoneX is showing high stability during turbulent times Strong earnings, low valuation, growing...
Alignment Healthcare: Innovation in U.S. Healthcare for Seniors
Holistic Care for Seniors: Alignment combines data-driven prevention with personalized care as part...
Robinhood is Riding the Trump Wave: Record Trading After Political Turnaround
Robinhood benefits massively from historically high trading volumes following Trump's tariff pause...
Rhythm Achieves Breakthrough in Rare Obesity – Study Success Fuels Stock Expectations
• Success with IMCIVREE®: Rhythm achieves breakthrough in previously untreatable form of obesity...
Cloudflare Acquires Outerbase – AI Applications Made Easy
• Data for everyone: Cloudflare acquires Outerbase and enables the development of AI-driven apps...
Hims & Hers: CEO Dudum Aims to Gain Market Share During the Crisis
Despite FDA setback and stock plunge, Hims is focusing on expansion rather than retreat – with a...
Education Without a Federal Department? Duolingo Could Profit From Trump's Plans!
• Trump's call for the abolition of the Department of Education brings private educational providers...
Cloudflare: From CDN Provider to AI Infrastructure Player – Analysts see Potential for Doubling Stock Price
Cloudflare grows from a CDN provider to an AI infrastructure pioneer – fueled by AIaaS and network...
Catalyst Pharmaceuticals: High-Growth Specialist for Rare Diseases
Successful with Orphan Drugs: Catalyst excels with high-margin niche products like FIRDAPSE...
Liberty Media Picks up the pace in Terms of Formula 1
Why Netflix, LVMH and Brad Pitt are part of the new F1 strategy – and what investors can gain from...
Robinhood Launches an Event Trading Platform – the Stock Rises by 7%
Robinhood expands its trading offerings, allowing investors to trade event contracts, including bets...
Duolingo: AI as a Growth Driver – is There a Second Chance for Investors now?
• Data advantage as a moat: With over one billion language exercises daily , Duolingo perfects...
Robinhood Pays a $29.75 Million Fine – the Stock Plummets, but ARK Capitalizes on the low
Robinhood under pressure: The online broker pays a fine of $29.75 million due to compliance violations,...
Arcutis Biotherapeutics: Cortisone-Free Ointment ZORYVE as a new Alternative for Eczema
Rapid Revenue Increase: ZORYVE is growing with +471% revenue in 2024 and establishing itself as an alternative...
Newmont: Gold Giant With Dwindling Profitability or an Underappreciated Opportunity?
Acquisition of Newcrest leads to challenges: The integration of new mines proves costly and burdens...
Robinhood: Trump's Announcement of a Strategic Crypto Reserve Boosts the Broker
• Trump's announcement of a strategic crypto reserve boosts the crypto market by $330 billion – Robinhood...
TransMedics: Pioneer of Transplantation Technology Defies Short-Seller Attack and Grows Rapidly
Record revenues despite controversies : TransMedics surpasses all expectations with a quarterly revenue...
Robinhood: My favorite under pressure – Now the perfect buying opportunity?
• Is Robinhood stock attractive again after the correction? Analysts see great potential with price...
Innodata: AI Partner of Big Techs – Stock Triples in a Few Months
• Rapid Growth: Revenue increased by 127% in Q4 – strong demand from big tech customers drives...
FDA Decision Strains Hims & Hers – Focus on Quarterly Numbers This Evening
• Production of GLP-1 Analogues Ends: With the end of the Wegovy supply shortage, Hims & Hers...
FDA Decision Affects Hims & Hers – Focus on Quarterly Results This Evening
• Production of GLP-1 mimetics ends: With the end of the Wegovy supply shortage, Hims & Hers...